Lampit

nifurtimox

Tablet (oral) · NDA 213464

Last listed protection ends

August 6, 2027

The FDA lists 1 exclusivity for Lampit, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities